A review of 31 studies showed that a fecal immuno chemical test (FIT), noninvasive test that identifies hidden blood in stool, is effective in detecting colorectal cancer. This is the strongest evidence yet that average-risk patients can safely avoid getting a colonoscopy unless they have an abnormal FIT result.